FR3122085B1 - Compositions pharmaceutique et nutraceutique pour la prevention et le traitement de maladies neurodegeneratives - Google Patents

Compositions pharmaceutique et nutraceutique pour la prevention et le traitement de maladies neurodegeneratives Download PDF

Info

Publication number
FR3122085B1
FR3122085B1 FR2104264A FR2104264A FR3122085B1 FR 3122085 B1 FR3122085 B1 FR 3122085B1 FR 2104264 A FR2104264 A FR 2104264A FR 2104264 A FR2104264 A FR 2104264A FR 3122085 B1 FR3122085 B1 FR 3122085B1
Authority
FR
France
Prior art keywords
pharmaceutical
prevention
treatment
neurodegenerative diseases
nutraceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2104264A
Other languages
English (en)
Other versions
FR3122085A1 (fr
Inventor
Laurent Moy
Maxime Robin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Aroma Science
Original Assignee
Laboratoire Aroma Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Aroma Science filed Critical Laboratoire Aroma Science
Priority to FR2104264A priority Critical patent/FR3122085B1/fr
Priority to CN202280035686.0A priority patent/CN117957008A/zh
Priority to PCT/EP2022/060761 priority patent/WO2022223814A1/fr
Priority to US18/287,342 priority patent/US20240197804A1/en
Priority to EP22724753.3A priority patent/EP4326301A1/fr
Publication of FR3122085A1 publication Critical patent/FR3122085A1/fr
Application granted granted Critical
Publication of FR3122085B1 publication Critical patent/FR3122085B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A61K36/835—Aquilaria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/89—Cyperaceae (Sedge family)
    • A61K36/8905—Cyperus (flatsedge)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne les domaines pharmaceutique et nutraceutique et, plus spécifiquement, une composition comprenant un extrait issu d’une combinaison de plantes pour la prévention et/ou le traitement d’une maladie neurodégénérative.
FR2104264A 2021-04-23 2021-04-23 Compositions pharmaceutique et nutraceutique pour la prevention et le traitement de maladies neurodegeneratives Active FR3122085B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR2104264A FR3122085B1 (fr) 2021-04-23 2021-04-23 Compositions pharmaceutique et nutraceutique pour la prevention et le traitement de maladies neurodegeneratives
CN202280035686.0A CN117957008A (zh) 2021-04-23 2022-04-22 用于预防和治疗神经***变性疾病的包含植物混合物的药物组合物和营养组合物
PCT/EP2022/060761 WO2022223814A1 (fr) 2021-04-23 2022-04-22 Composition pharmaceutique et nutraceutique comprenant un mélange de plantes pour la prevention et le traitement de maladies neurodegeneratives
US18/287,342 US20240197804A1 (en) 2021-04-23 2022-04-22 Pharmaceutical and nutraceutical composition comprising a mixture of plants for the prevention and treatment of neurodegenerative diseases
EP22724753.3A EP4326301A1 (fr) 2021-04-23 2022-04-22 Composition pharmaceutique et nutraceutique comprenant un mélange de plantes pour la prevention et le traitement de maladies neurodegeneratives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2104264A FR3122085B1 (fr) 2021-04-23 2021-04-23 Compositions pharmaceutique et nutraceutique pour la prevention et le traitement de maladies neurodegeneratives
FR2104264 2021-04-23

Publications (2)

Publication Number Publication Date
FR3122085A1 FR3122085A1 (fr) 2022-10-28
FR3122085B1 true FR3122085B1 (fr) 2024-03-01

Family

ID=76283980

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2104264A Active FR3122085B1 (fr) 2021-04-23 2021-04-23 Compositions pharmaceutique et nutraceutique pour la prevention et le traitement de maladies neurodegeneratives

Country Status (5)

Country Link
US (1) US20240197804A1 (fr)
EP (1) EP4326301A1 (fr)
CN (1) CN117957008A (fr)
FR (1) FR3122085B1 (fr)
WO (1) WO2022223814A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018038292A1 (fr) * 2016-08-25 2018-03-01 경희대학교 산학협력단 Composition pharmaceutique contenant comme principe actif un extrait de cinnamomum camphora et destinée à la prévention et au traitement de maladies neurologiques

Also Published As

Publication number Publication date
FR3122085A1 (fr) 2022-10-28
CN117957008A (zh) 2024-04-30
EP4326301A1 (fr) 2024-02-28
WO2022223814A1 (fr) 2022-10-27
WO2022223814A9 (fr) 2022-12-15
US20240197804A1 (en) 2024-06-20

Similar Documents

Publication Publication Date Title
MA39219A1 (fr) Nouveaux composés inhibiteurs de la kinase lrrk2 utilisés pour le traitement du parkinson, de l’alzheimer et de la sclérose latérale amyotrophique
MA47447B1 (fr) 2-hétéroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides pour le traitement du cancer
MA30163B1 (fr) Anticorps monoclonaux specifiques pour a beta 1-42 ayant des proprietes therapeutiques
MA33726B1 (fr) Composes de dioxyde d'iminothiadiazine comme inhibiteurs de bace, compositions et leur utlisation
MA46665B1 (fr) Composés de tyrosine tyrosine de peptide cyclique couplés à un anticorps en tant que modulateurs des récepteurs du neuropeptide y
MA35513B1 (fr) Compositions pharmaceutiques comprenant 40 - o - ( 2 - hydroxy) éthyl - rapamycine
MA30337B1 (fr) Anticorps
MA39225A1 (fr) 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tétrahydropyridines utilisées en tant qu'inhibiteurs de bace1 dans le traitement de la maladie d'alzheimer
MA40955A (fr) 2-amino-6-(difluorométhyl)-5,5-difluoro-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1
MA54133B1 (fr) Composés d'aminopyrazine diol utilisés comme inhibiteurs de pi3k-y
MA38688A1 (fr) Composition solide pour administration orale contenant de l'acide ibandronique ou un sel pharmaceutiquement acceptable de celui-ci et de la vitamine d
MA54663A1 (fr) Composition pharmaceutique aqueuse d'un anticorps anti-il17a et son utilisation
MA37763A1 (fr) Difluoro-hexahydro-cyclopentaoxazinyles et difluoro-hexahydro-benzooxazinyles en tant qu'inhibiteurs de bace1
MA53765A1 (fr) Tubulysines et conjugués tubulysines-protéines
Park et al. Amyrin attenuates scopolamine-induced cognitive impairment in mice
MA40082B1 (fr) Nouveau compose de substitution sphingosine phosphate utile traitement maladie rhumatisme
BR112022021743A2 (pt) Compostos e métodos direcionando a interleucina-34
MA37670B1 (fr) Anticorps anti-transglutaminase 2
FR2913885B1 (fr) Utilisation de la citrulline pour le traitement des pathologies liees a une augmentation de la carbonylation des proteines
MA54318B1 (fr) Formulations de capsules
FR3122085B1 (fr) Compositions pharmaceutique et nutraceutique pour la prevention et le traitement de maladies neurodegeneratives
MA47082B1 (fr) Amides aromatiques d'acide carboxylique en tant qu'antagonistes des recepteurs bradykinin b1
MA39421A (fr) Peptides dérivés de l'ezrine et compositions pharmaceutiques correspondantes
WO2019071093A1 (fr) Composés alkamide et utilisations associées
MA29812B1 (fr) N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides cycliques, procedes pour leur preparation et leur utilisation en tant que substances pharmaceutiques

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20221028

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4